, Tracking Stock Market Picks
Enter Symbol:

up 209.21 %

COVIDIEN LTD. COMMON SHARES (COV) rated Buy with price target $48 by Caris & Company

Posted on: Friday,  Sep 10, 2010  9:25 AM ET by Caris & Company

Caris & Company rated Buy COVIDIEN LTD. COMMON SHARES (NYSE: COV) on 09/10/2010. Previously Caris & Company rated Above Average COVIDIEN LTD. COMMON SHARES
(NYSE: COV) on 04/17/2009., when the stock price was $34.51. Since then, COVIDIEN LTD. COMMON SHARES has gained 209.21% as of 01/26/2016's recent price of $106.71.
If you would have followed the previous Caris & Company's recommendation on COV, you would have gained 209.21% of your investment in 2475 days.

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-Based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2010 9:25 AM Buy
36.85 48.00
as of 12/31/2010
1 Week up  3.73 %
1 Month up  13.40 %
3 Months up  18.71 %
1 YTD down  -0.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2009 9:25 AM Buy
45.32 50.00
7/31/2009 9:25 AM Buy
38.15 44.00
4/17/2009 9:25 AM Buy
34.51 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy